
1CE

1CE
Advances in biotechnology are also applied to biomateials for bone regeneration. In this regard, the latest developments in bone replacement grafts, include, among others, the modification of certain xenografts by supplementing them with collagen and other excipients. This, may potentially improve the clinical performance, directly impacting in a benefit for the patient.
The webinar will deal with the main limitations of the most commonly used biomaterials. Afterwards, the last updates in bone replacement grafts will be introduced. It will focus on the clinical advances, benefits and applications of GTO, a pre-hydrated cortico-cancellous heterologous bone mix blended with a thermosensitive copolymer (TSV Gel). The scientific evidence and clinical rationales will be presented, including a recently randomized clinical trial recently completed on socket augmentation, including clinical, radiographical and histological outcomes.
Tribune Group GmbH is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Tribune Group GmbH and Dental Tribune International GmbH, recognized through ADA CERP from 5/1/24 - 6/30/27.
